| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916865 | Pathology - Research and Practice | 2014 | 7 Pages |
Abstract
The frequent expression of ALCAM (70.3%) in head and neck squamous cell carcinomas does not support an important role for HNSCC biology. The increased levels of ALCAM suggest the existence of a therapeutic window for potential anti-ALCAM therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Till Sebastian Clauditz, Kirsten von Rheinbaben, Patrick Lebok, Sarah Minner, Michael Tachezy, Kerstin Borgmann, Rainald Knecht, Guido Sauter, Waldemar Wilczak, Marco Blessmann, Adrian Münscher,